FLAXEN

Serial Number 98162030
Registration 7657837
700

Registration Progress

Application Filed
Sep 1, 2023
Under Examination
Approved for Publication
Dec 3, 2024
Published for Opposition
Dec 3, 2024
Registered
Jan 21, 2025

Trademark Image

FLAXEN

Basic Information

Serial Number
98162030
Registration Number
7657837
Filing Date
September 1, 2023
Registration Date
January 21, 2025
Published for Opposition
December 3, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 21, 2025
Registration
Registered
Classes
005

Rights Holder

The Trustees of the Urban Pharmaceuticals

17
Address
Suite 700
3033 Wilson Blvd.
Arlington, VA 22201

Ownership History

The Trustees of the Urban Pharmaceuticals

Original Applicant
17
Arlington, VA

The Trustees of the Urban Pharmaceuticals

Owner at Publication
17
Arlington, VA

The Trustees of the Urban Pharmaceuticals

Original Registrant
17
Arlington, VA

Legal Representation

Attorney
Jeannette Carmadella

USPTO Deadlines

Next Deadline
1901 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-01-21)
Due Date
January 21, 2031
Grace Period Ends
July 21, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

24 events
Date Code Type Description Documents
Sep 15, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 15, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 15, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 21, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 21, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Dec 3, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 3, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 27, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 4, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 1, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 1, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 1, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 3, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 3, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 3, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 31, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 30, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 30, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 30, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 30, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 30, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 30, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 27, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 5, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Anti-inflammatories; Anti-inflammatory and antipyretic preparations; pharmaceutical preparations for the treatment of pain and inflammation; Analgesics, namely, naproxen sodium
First Use Anywhere: Mar 1, 2014
First Use in Commerce: Mar 1, 2014

Classification

International Classes
005